Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000444054 | SCV000512015 | benign | not specified | 2015-04-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000641173 | SCV000762810 | likely benign | Pyridoxine-dependent epilepsy | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001310863 | SCV001500834 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | ALDH7A1: BP4, BP7 |
Ambry Genetics | RCV002379289 | SCV002691329 | likely benign | Inborn genetic diseases | 2017-06-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000641173 | SCV004050206 | benign | Pyridoxine-dependent epilepsy | 2023-04-11 | criteria provided, single submitter | clinical testing |